Prenatal screening for cystic fibrosis carriers: Does the method of testing affect the longer-term understanding and reproductive behaviour of women?

Prenatal Diagnosis

Volumn 17, Issue 9, 1997, Pages 853-860

  Mennie, M E ^a   Axworthy, D ^b   Liston, W A ^c   Brock, D J H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Simpson Memorial Maternity Pavilion   (United Kingdom)

Author keywords

Couple method; Cystic fibrosis; Patient understanding; Prenatal carrier screening; Two step method

Indexed keywords

ARTICLE; COMPREHENSION; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE CARRIER; FEMALE; GENETIC COUNSELING; HUMAN; HUMAN EXPERIMENT; INTERMETHOD COMPARISON; NORMAL HUMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SCREENING TEST; TIME;

CYSTIC FIBROSIS; FEMALE; FETAL DISEASES; GENETIC COUNSELING; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HETEROZYGOTE DETECTION; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; REPRODUCTION; RISK FACTORS;

EID: 0030883595     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199709)17:9<853::AID-PD151>3.0.CO;2-3     Document Type: Article

References (25)

1. Avorn, J., Sumerai, S.B. (1983). Improving drug therapy through educational outreach, N. Engl. J. Med., 308, 1457-1463.
2. Axworthy, D., Brock, D.J.H., Bobrow, M., Marteau, T.M. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up, Lancet, 347, 1443-1446.
3. Bekker, H., Modell, M., Denniss, G., Silver, A., Mathew, C., Bobrow, M., Marteau, T. (1993). Uptake of cystic fibrosis testing in primary care: supply push or demand pull?, Br. Med J., 306, 1584-1586.
4. Bekker, H., Denniss, G., Modell, M., Bobrow, M., Marteau, T. (1994). The impact of population based screening for carriers of cystic fibrosis, J. Med. Genet., 31, 364-368.
5. Boulton, M., Cummings, C., Williamson, R. (1996). The views of general practitioners on community carrier screening for cystic fibrosis. Br. J. Gen. Pract., 46, 299-301.
6. Brock, D.J.H., Shrimpton, A.E., Jones, C., McIntosh, I. (1991). Cystic fibrosis: the new genetics, J. R. Soc. Med., 84 (Suppl. 18), 2-9.
7. Cuckle, H.S., Richardson, G.A., Sheldon, T. A., Quirke, P. (1995). Cost effectiveness of antenatal screening for cystic fibrosis, Br. Med. J., 311, 1460-1464.
8. Faden, R.R., Chwalow, A.J., Orel-Crosby, E., Holtzman, N.A., Chase, G.A., Leonard, C.O. (1985). What participants understand about a maternal serum alpha-fetoprotein screening program, Am. J. Public Health, 75, 1381-1384.
9. Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., Harris, R. (1993). Cystic fibrosis carrier testing in early pregnancy by general practitioners, Br. Med. J., 306, 1580-1583.
10. Harris, H., Scotcher, D., Hartley, N., Wallace, A., Craufurd, D., Harris, R. (1996). Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice, Br. J. Gen. Pract., 46, 225-227.
11. Ley, P. (1988). Communicating with Patients, Improving Communication, Satisfaction and Compliance, London: Croom Helm.
12. Livingstone, J., Axton, R.A., Mennie, M., Gilfillan, A., Brock, D.J.H. (1993). A preliminary trial of couple screening for cystic fibrosis: designing an appropriate information leaflet, Clin. Genet., 43, 57-62.
13. Livingstone, J., Axton, R.A., Gilfillan, A., Mennie, M., Compton, M., Liston, W.A., Calder, A.A., Gordon, A.J., Brock, D.J.H. (1994). Antenatal screening for cystic fibrosis: a trial of the couple model, Br. Med. J., 308, 1459-1462.
14. Loader, S., Caldwell, P., Kozyra, A., Levenkron, J.C., Boehm, C.D., Kazazian, H.H., Rowley, P.T. (1996). Cystic fibrosis carrier population screening in the Primary Care setting. Am. J. Hum. Genet., 59, 234-247.
15. Mennie, M.E., Gilfillan, A., Compton, M., Curtis, L., Liston, W.A., Pullen, I., Whyte, D.A., Brock, D.J.H. (1992a). Prenatal screening for cystic fibrosis, Lancet, 340, 214-216.
16. Mennie, M.E., Liston, W.A., Brock, D.J.H. (1992b). Prenatal cystic fibrosis carrier testing: designing an information leaflet to meet the specific needs of the target population, J. Med. Genet., 29, 308-312.
17. Mennie, M., Compton, M., Gilfillan, A., Axton, R.A., Liston, W.A., Pullen, I., Whyte, D., Brock, D.J.H. (1993a). Prenatal screening for cystic fibrosis: attitudes and responses of participants, Clin. Genet., 44, 102-106.
18. Mennie, M., Compton, M., Gilfillan, A., Liston, W.A., Pullen, I., Whyte, D.A., Brock, D.J.H. (1993b). Prenatal screening for cystic fibrosis: psychological effects on carriers and their partners, J. Med. Genet., 30, 543-548.
19. Mennie, M.E., Gilfillan, A., Compton, M.E., Liston, W.A., Brock, D.J.H. (1993c). Prenatal cystic fibrosis carrier screening: factors in a woman's decision to decline testing, Prenat. Diagn., 13, 807-814.
20. Miedzybrodzka, Z.H., Hall, M.H., Mollison, J., Templeton, A., Russell, I.T., Dean, J.C.S., Kelly, K.F., Marteau, T.M., Haites, N.E. (1995). Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening, Br. Med. J., 310, 353-357.
21. Morris, J.K., Oppenheimer, P.M. (1995). Cost comparison of different methods of screening for cystic fibrosis, J. Med. Screening, 2, 22-21.
22. Wald, N.J. (1991). Couple screening for cystic fibrosis, Lancet, 338, 1318-1319.
23. Watson, E.K., Mayall, E., Chapple, J., Dalziel, M., Harrington, K., Williams, C., Williamson, R. (1991). Screening for carriers of cystic fibrosis through primary health care services, Br. Med. J., 303, 504-507.
24. Watson, E.K., Mayall, E.S., Lamb, J., Chapple, J., Williamson, R. (1992). Psychological and social consequences of community carrier screening programme for cystic fibrosis, Lancet, 340, 217-220.
25. Wilfond, B.S., Fost, N. (1990). The cystic fibrosis gene: medical and social implications for heterozygote detection, J. Am. Med. Assoc., 263, 2777-2783.